Filing Details
Esperion Therapeutics, Inc. (NASDAQ:ESPR) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:ESPR
Esperion Therapeutics, Inc. (ESPR) Reports Material Event to SEC
Filing Details Esperion Therapeutics, Inc. (NASDAQ:ESPR) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context…
Market Context
Esperion Therapeutics, Inc.'s stock currently trades at $3.19 with a market capitalization of $804.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Esperion Therapeutics, Inc.'s stock.
All SEC filings for Esperion Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ESPR Stock Page
Frequently Asked Questions
Where can I read ESPR's SEC filings?
Browse all filings on our ESPR SEC filings page.
What types of SEC filings does Esperion Therapeutics, Inc. file?
Public companies like Esperion Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.